Clinical trial
COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC
NCT02484664 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 15, 2016
- Completion date
- November 19, 2018
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lymphangioleiomyomatosis (lam)